Vatche Demirjian

Director, Global Medical Excellence Lead at Pfizer

Vatche Demirjian, PharmD, RPh, is an experienced professional in the pharmaceutical industry, currently serving as the Director and Global Medical Excellence Lead at Pfizer. Previous roles include Regional Medical Advisor at KalVista Pharmaceuticals, Medical Science Liaison at Forma Therapeutics, and Medical Science Liaison in Hematology/Nephrology at Alexion Pharmaceuticals, where Vatche also held the position of Manager for Global Medical Information and Medical Review. Vatche began the career as a Hospital Pharmacist at Robert Wood Johnson University Hospital and completed a residency there. Vatche holds a Doctor of Pharmacy (PharmD) degree from the Massachusetts College of Pharmacy and Health Sciences and has furthered skills with education from Harvard Business School.

Location

Paramus, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


Pfizer

604 followers

Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.